Isolated case reports have demonstrated the beneficial effects of metformin (312, 313), topiramate (314), and bariatric surgery (315, 316) on weight reduction, visceral fat mass, and insulin sensitivity in patients with CAH. Here, INS is linked to congenital adrenal hyperplasia.